Source link : https://newshealth.biz/health-news/safety-data-on-the-novel-pancreatic-cancer-drug-available-by-early-access/
The investigational pancreatic cancer drug daraxonrasib demonstrated promising efficacy and was associated with high-grade treatment-related adverse events in about a third of previously treated patients in a phase I/II study. The FDA recently said that it was allowing the drug’s maker to initiate an expanded access program, after the company announced an “unprecedented” improvement in […]
The post Safety Data on the Novel Pancreatic Cancer Drug Available by Early Access first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-06 22:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8